These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 9099643

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
    Bhaijee F, Locketz ML, Krige JE.
    S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
    [Abstract] [Full Text] [Related]

  • 5. [Surgical therapy of hepatic fibrolamellar carcinoma].
    Meriggi F, Forni E.
    Ann Ital Chir; 2007 Nov; 78(1):53-8. PubMed ID: 17518332
    [Abstract] [Full Text] [Related]

  • 6. Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
    Akuta N, Suzuki F, Kobayashi M, Hara T, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Saitoh S, Ikeda K, Kumada H.
    J Med Virol; 2014 Jan; 86(1):131-8. PubMed ID: 24123090
    [Abstract] [Full Text] [Related]

  • 7. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
    McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F, Dunaway E, Williams J.
    Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
    [Abstract] [Full Text] [Related]

  • 8. Hepatocellular carcinoma--an update.
    Sinha SN.
    P N G Med J; 1985 Jun; 28(2):83-8. PubMed ID: 2417429
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J, Zichová M, Vodák M.
    Sb Lek; 1993 Jun; 94(4):311-5. PubMed ID: 7527585
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M, Zhao J, Lu F.
    Oncotarget; 2016 Jan 26; 7(4):3702-8. PubMed ID: 26784252
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J, Liu J, Lee MH, Jen CL, Batrla-Utermann R, Lu SN, Wang LY, You SL, Yang HI, Chen CJ.
    J Gastroenterol Hepatol; 2016 Dec 26; 31(12):1971-1977. PubMed ID: 27118149
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K, Shigematsu H, Irie K, Ishibashi H.
    Hepatogastroenterology; 2003 Dec 26; 50(54):2022-7. PubMed ID: 14696457
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Survival from hepatocellular carcinoma at a cancer hospital in Pakistan.
    Yusuf MA, Badar F, Meerza F, Khokhar RA, Ali FA, Sarwar S, Faruqui ZS.
    Asian Pac J Cancer Prev; 2007 Dec 26; 8(2):272-4. PubMed ID: 17696722
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.